These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8084454)

  • 1. Nocturnal intermittent peritoneal dialysis.
    Woodrow G; Turney JH; Cook JA; Gibson J; Fletcher S; Stewart AJ; Brownjohn AM
    Nephrol Dial Transplant; 1994; 9(4):399-403. PubMed ID: 8084454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with nocturnal intermittent peritoneal dialysis].
    Brunkhorst R; Wrenger E; Koch KM
    Dtsch Med Wochenschr; 1993 Jan; 118(1-2):6-12. PubMed ID: 8420776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous ambulatory peritoneal dialysis in children. 2 years' experience].
    Heller-Ackeret C; Ertelt W; Leumann EP
    Schweiz Med Wochenschr; 1982 Jun; 112(24):859-64. PubMed ID: 7051275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequacy of solute and water removal in children treated with nightly intermittent peritoneal dialysis.
    Edefonti A; Picca M; Ghio L; Bassi S; Cattarelli D; Leccese V
    Adv Perit Dial; 1992; 8():402-5. PubMed ID: 1361833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nightly intermittent peritoneal dialysis to initiate peritoneal dialysis.
    Ramalakshmi S; Bernardini J; Piraino B
    Adv Perit Dial; 2003; 19():111-4. PubMed ID: 14763045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term successful nocturnal intermittent peritoneal dialysis: a ten-year case study.
    Trivedi HS; Twardowski ZJ
    Adv Perit Dial; 1994; 10():81-4. PubMed ID: 7999870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis: three years' experience.
    Ramos JM; Gokal R; Siamopolous K; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(206):165-86. PubMed ID: 6611839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.
    Madden MA; Zimmerman SW; Simpson DP
    Clin Nephrol; 1981 Dec; 16(6):293-9. PubMed ID: 6797767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy cost and complication rate of APD and CAPD as long-term outpatient treatments for renal failure.
    King LK; Kingswood JC; Sharpstone P
    Adv Perit Dial; 1992; 8():123-6. PubMed ID: 1361767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in calculations of dialysis adequacy in patients using nightly intermittent peritoneal dialysis compared to CAPD.
    Friedlander MA; Rahman M; Tessman MJ; Hanslik TM; Ferrara KA; Newman LN
    Adv Perit Dial; 1995; 11():93-6. PubMed ID: 8534747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.
    Strauss FG; Holmes DL; Dennis RL
    Adv Perit Dial; 1995; 11():110-3. PubMed ID: 8534681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.
    Chuang YW; Shu KH; Yu TM; Cheng CH; Chen CH
    Nephrol Dial Transplant; 2009 May; 24(5):1603-8. PubMed ID: 19103738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous ambulatory peritoneal dialysis (CAPD). 3 years' therapeutic experience in 100 patients].
    Rottembourg J; de Groc F; Jacq D; Issad B; El Shahat Y; Aqraflotis A; Seidler A; Legrain M
    Z Urol Nephrol; 1983 Mar; 76(3):191-201. PubMed ID: 6858416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients.
    Locatelli AJ; Marcos GM; Gómez MG; Alvarez SA; DeBenedetti LC
    Adv Perit Dial; 1999; 15():193-6. PubMed ID: 10682100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve months' experience with continuous ambulatory and intermittent peritoneal dialysis.
    Lacke C; Senekjian HO; Knight TF; Frazier M; Hatlelid R; Kozak M; Baker P; Weinman EJ
    Arch Intern Med; 1981 Feb; 141(2):187-90. PubMed ID: 7458514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002).
    Kavanagh D; Prescott GJ; Mactier RA
    Nephrol Dial Transplant; 2004 Oct; 19(10):2584-91. PubMed ID: 15304559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and survival in different peritoneal dialysis modalities.
    Al-Hilali N; Al-Humoud H; Nampoory M; Ninan A; Johny K
    Ther Apher Dial; 2007 Apr; 11(2):101-6. PubMed ID: 17381530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.